BNKL (Bionik Laboratories) Total Equity: $-1.64 Mil (As of Mar. 2023)


BNKL Bionik Laboratories Corp BNKL
12 GF Score
Price $0.00
View Full Analysis

What is Bionik Laboratories Total Equity?

Bionik Laboratories BNKL -99.00% 12 Total Equity is $-1.64 Mil as of Mar. 2023. GuruFocus rates BNKL with a GF Score™ of 12/100.

Bionik Laboratories's total equity for the quarter that ended in Mar. 2023 was $-1.64 Mil.

This is Residual interest, including minority interest, that remains in the assets of the enterprise after deducting its liabilities. Equity is increased by owners’ investments and by comprehensive income, and it is reduced by distributions to the owners.

Bionik Laboratories Total Equity Historical Data

* Premium members only.

The historical data trend for Bionik Laboratories's Total Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Bionik Laboratories Total Equity Chart

Bionik Laboratories Annual Data
Trend Dec14 Dec15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23
Total Equity
Get a 7-Day Free Trial Premium Member Only Premium Member Only 27.41 13.32 3.28 2.93 -1.64

Bionik Laboratories Quarterly Data
Jun18 Sep18 Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23
Total Equity Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 2.93 1.60 0.52 -0.52 -1.64
BNKL
12GF Score
Bionik Laboratories Corp BNKL
Total Equity is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Bionik Laboratories Total Equity Calculation

Total Equity and Total Liabilities are the two components for Total Assets.

Bionik Laboratories's Total Equity for the fiscal year that ended in Mar. 2023 is calculated as

Total Equity=Total Assets(Q: Mar. 2023 )-Total Liabilities(Q: Mar. 2023 )
=3.362-5.003
=-1.64

Bionik Laboratories's Total Equity for the quarter that ended in Mar. 2023 is calculated as

Total Equity=Total Assets(Q: Mar. 2023 )-Total Liabilities(Q: Mar. 2023 )
=3.362-5.003
=-1.64

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Total Equity →
What does a Total Equity of $-1.64 Mil mean?
Bionik Laboratories (BNKL) has a Total Equity of $-1.64 Mil as of Mar. 2023. The total amount of equity as record on a company's balance sheet. View historical data for Bionik Laboratories and its competitors.
Is Bionik Laboratories' Total Equity too high?
Bionik Laboratories' current Total Equity is $-1.64 Mil. Overall, Bionik Laboratories has a GF Score™ of 12/100, reflecting its overall financial health beyond just this single metric.
How does Bionik Laboratories' Total Equity compare to ARPC and GRST?
Bionik Laboratories' Total Equity of $-1.64 Mil can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Equity for a Healthcare Providers & Services company?
A good Total Equity depends on the Healthcare Providers & Services industry context. However, Total Equity should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Equity mean?
A high Total Equity can signal that a stock is expensive relative to its fundamentals. The total amount of equity as record on a company's balance sheet. View historical data for Bionik Laboratories and its competitors. Bionik Laboratories's current Total Equity is $-1.64 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Bionik Laboratories stock overvalued right now?
Bionik Laboratories (BNKL) has a current Total Equity of $-1.64 Mil. The current Total Equity is $-1.64 Mil. Bionik Laboratories' overall GF Score™ is 12/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Equity calculated?
Total Equity is calculated from a company's financial statements. For Bionik Laboratories (BNKL), the current Total Equity is $-1.64 Mil as of Mar. 2023. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Bionik Laboratories Business Description

Address 80 Coolidge Hill Road, Watertown, MA, USA, 02472
Bionik Laboratories Corp is a healthcare company focused on improving the quality of life of millions of people with neurological or mobility impairments by combining artificial intelligence and robotics technology to help individuals from hospital to home regain mobility, enhance autonomy, and regain self-esteem. The company uses artificial intelligence and machine learning technologies to make rehabilitation methods and processes smarter and more intuitive to deliver a greater recovery for patients with neurological or mobility impairments. Its products The InMotion ARM, and InMotion ARM/HAND are robotic therapies for the upper limbs.
12GF Score

Get the complete analysis for BNKL

Total Equity is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.00
Price